Halo Labs Inc (NEO:HALO) Undervalued Extractor’s Strategic Direction

By |

Watch

Midas Letter

The Digital Businesss Channel for Cannabis, Crypto and Technology Stocks.

**IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY**

Notice for Forward-Looking Information

Certain statements in this press release are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such forward-looking information includes that HALO Labs Inc will be a big, successful company in the cannabis sector; that cannabis use and sales will grow and HALO’s sales along with it; HALO’s intended acquisition of various foreign companies and expansion into the US market; that extraction is and will continue to be a fast growing and profitable sector of the cannabis industry; that HALO will reach $48M in revenues in 2019; HALO’s plans to produce concentrates and sell them in various locations throughout the world; that HALO could be granted licenses to expand; and that it will be able to carry out its business plans.

Readers are cautioned to not place undue reliance on forward-looking information. Forward looking information is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from those contemplated in the forward-looking information, and even if such actual results or events are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on HALO. Such risks and uncertainties include, among other things: that a regulatory approval that may be required for the intended acquisitions and subsequent sales are not obtained or are obtained subject to conditions that are not anticipated; growing competition for intended acquisitions in the cannabis industry; potential future competition in the markets HALO operates for sales; competitors may quickly enter the industry; general economic conditions in the US, Canada and globally; the inability to secure financing necessary to carry out its business plans; competition for, among other things, capital and skilled personnel; the possibility that government policies or laws may not permit legal cannabis sales or growth or that favorable laws in place may change; HALO not adequately protecting its intellectual property; interruption or failure of information technology systems; the cannabis market may not grow as expected; HALO’s technology may not achieve the expected results and its accomplishments may be limited; even if it is granted patents, it may not have success at licensing its technologies or sell its products at the rate expected; planned acquisitions and partnerships may not materialize because of inability to agree on terms with prospective partners or targets; HALO’s business plan also carries risk, including its ability to comply with all applicable governmental regulations in a highly regulated business; incubator risk investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal and foreign laws; and other regulatory risks relating to HALO’s business, financings and strategic acquisitions, including securities laws, trade rules, and foreign country regulation that is not the same as Canadian or US regulations.

DISCLAIMERS

PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buy or sell securities. James West, Global Financial Network Ltd. and Midas Letter Media Corp. and their owners, managers, employees, and assigns (collectively “the Company”) has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by HALO $300,000 US dollars for a newsletter campaign and certain banner ads, and a budget of $450,000 is in place to place newsletters in social and other media. In addition, the Company owns 40,000 shares of HALO, and will benefit from its price appreciation. This compensation and our share ownership in HALO is a major conflict with our ability to be unbiased, more specifically:

This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in our newsletter and on our website may be based on end-of- day or intraday data. We have been compensated by HALO to conduct investor awareness advertising and marketing for HALO. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the profiled company. The profiled company or its affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our newsletters experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public and non-public sources but is not researched or verified in any way whatsoever to ensure the information is correct.

SHARE OWNERSHIP. The Company, which includes the owner and publisher of the Midas Letter may own shares and/or stock options of this featured company and therefore has an additional incentive to see the featured company’s stock perform well. The Company will not notify the market when it decides to buy or sell shares of this profiled company in the market. The Company may be buying and selling additional shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

NOT AN INVESTMENT ADVISOR. The Company and its affiliates are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities.

Halo Labs Inc (NEO:HALO) (OTCMKTS:AGEEF (FRA:A9KN) Chief Revenue Officer David Orr joins Midas Letter in Los Angeles, California to discuss the company’s strategic direction. While the cannabis derivative industry has been becoming increasingly more competitive, Halo Labs has managed to distinguish themselves from the mass of brands with innovations within the portable ‘dabbing’ world, through commercialization of its Shatterizer and DabTabs vapourizer products.  DabTabs are ceramic based tablets that allow customers to customize their desired dosage. DabTabs can be filled with live resin, shatter, distillate in any concentration of CBD and THC. Among other developments, Halo Labs’ is also expanding across the United States, Europe and Latin America. A large focus of the Chief Revenue Officer is the large potential revenue streams stemming from the company’s expertise in cannabis extraction and providing quality white label products for others. Mr. Orr explains when analyzing the company’s financials and business streams coupled with its expertise and knowledge in extractions, the company is undervalued in comparison to its peers. 

 

**IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY**

Notice for Forward-Looking Information

Certain statements in this press release are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such forward-looking information includes that HALO Labs Inc will be a big, successful company in the cannabis sector; that cannabis use and sales will grow and HALO’s sales along with it; HALO’s intended acquisition of various foreign companies and expansion into the US market; that extraction is and will continue to be a fast growing and profitable sector of the cannabis industry; that HALO will reach $48M in revenues in 2019; HALO’s plans to produce concentrates and sell them in various locations throughout the world; that HALO could be granted licenses to expand; and that it will be able to carry out its business plans.

Readers are cautioned to not place undue reliance on forward-looking information. Forward looking information is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from those contemplated in the forward-looking information, and even if such actual results or events are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on HALO. Such risks and uncertainties include, among other things: that a regulatory approval that may be required for the intended acquisitions and subsequent sales are not obtained or are obtained subject to conditions that are not anticipated; growing competition for intended acquisitions in the cannabis industry; potential future competition in the markets HALO operates for sales; competitors may quickly enter the industry; general economic conditions in the US, Canada and globally; the inability to secure financing necessary to carry out its business plans; competition for, among other things, capital and skilled personnel; the possibility that government policies or laws may not permit legal cannabis sales or growth or that favorable laws in place may change; HALO not adequately protecting its intellectual property; interruption or failure of information technology systems; the cannabis market may not grow as expected; HALO’s technology may not achieve the expected results and its accomplishments may be limited; even if it is granted patents, it may not have success at licensing its technologies or sell its products at the rate expected; planned acquisitions and partnerships may not materialize because of inability to agree on terms with prospective partners or targets; HALO’s business plan also carries risk, including its ability to comply with all applicable governmental regulations in a highly regulated business; incubator risk investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal and foreign laws; and other regulatory risks relating to HALO’s business, financings and strategic acquisitions, including securities laws, trade rules, and foreign country regulation that is not the same as Canadian or US regulations.

 DISCLAIMERS

PAID ADVERTISEMENT.This communication is a paid advertisement and is not a recommendation to buy or sell securities. James West, Global Financial Network Ltd. and Midas Letter Media Corp. and their owners, managers, employees, and assigns (collectively “the Company”) has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by HALO $300,000 US dollars for an article and video campaign and certain banner ads, and a budget of $450,000 is in place to place newsletters in social and other media.

This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in our newsletter and on our website may be based on end-of- day or intraday data. We have been compensated by HALO to conduct investor awareness advertising and marketing for HALO. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the profiled company. The profiled company or its affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our newsletters experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public and non-public sources but is not researched or verified in any way whatsoever to ensure the information is correct.

SHARE OWNERSHIP. The Company, which includes the owner and publisher of the Midas Letter may own shares and/or stock options of this featured company and therefore has an additional incentive to see the featured company’s stock perform well. The Company will not notify the market when it decides to buy or sell shares of this profiled company in the market. The Company may be buying and selling additional shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

NOT AN INVESTMENT ADVISOR.The Company and its affiliates are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

INDEMNIFICATION/RELEASE OF LIABILITY.By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

RISK OF INVESTING.Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don’t trade with money you can’t afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities.

 

Transcript

James West: David Orr joins me now. He’s the Chief Revenue Officer at Halo Labs. David, welcome.

David Orr: Thank you. Thanks for having me.

James West: Yeah, David, so as Chief Revenue Officer, your ass is on the line every day, obviously?

David Orr: Yes, yes, in some ways, yeah. Some days more than others.

James West: Yeah, and so, we’re familiar with the product line of Halo Labs; I’m more interested in the strategic direction. Like, what made you come up with a thing like a Dab Tab, which is something that I’ve never seen anywhere? Nobody else has them; I’m assuming there’s some IP around that?

David Orr: Yes, there is, definitely, yeah. You know, great question, and we’re really looking at Dab Tabs with the same level of excitement and differentiation. You know, I think, and I think the industry in and of itself, is like most, somewhat Me Too. So there’s tremendous amount of competition, a tremendous amount of brands and product offerings that basically are the same thing. We look at Dab Tabs as a really true breakthrough innovation in the cannabis industry, and it’s a ceramic based tablet that you can fuse with micro-dosing kind of mindset and allow it to be dosed across any number of potential fills. You could fill it with live resin, shatter, distillate, etcetera. So CBD, THC. So as we think about the opportunities for the product, we really do see it as something that not only from an innovation and news perspective is great, but also something that actually delivers different benefits to consumers. 

James West: Yeah. So the  precise dose concept is something that I think is part of what’s alienating a whole potential audience for cannabis, in that if you smoke dried flower, you don’t know how much you’re inhaling; you don’t know exactly what you’re getting. When you consume an edible, you don’t know exactly how much you’re eating or when it’s going to hit you, or how long it’s going to last. So precision dosing, is that targeting an older, more mature audience?

David Orr: I’d actually say it’s targeting a broad audience, not necessarily older mature. I think as the market matures, I think now as cannabis becomes hopefully, you know, a much more kind of common, enjoyable experience across consumers, I think you’re going to see  people that are going to, not only from an education perspective, but also just from the perspective of having control, they’re going to want that.

So again, we think about how the category – you asked me about strategy – I think we’re constantly thinking about how the industry is going to evolve, and I think being able to have measured doses is something that consumers are going to be looking for across the board. This product is one of the first; I would assume that there’ll be more downstream.

James West: Yeah, you bet. We heard from CEO Kiran Sidhu earlier, and he sort of indicated that the company is on track for fantastic revenue this year. How do you transplant this success story onto the other states as they become legal?     

David Orr: Again, you know, and yeah, we are optimistic about what we will be able to do here, and Kiran particularly; I laughed because you talked about, you know, where I fall, and yeah, that’s the kind of pressure that we’re self-imposing a little bit, because we really are optimistic about what we can do.

With that said, I think our kind of footprint really is twofold, and I’m sure Kiran talked about this; you know, we offer branded products, which you see an example of here, and also white label. And as we look to expand not only in the states that we’re in but in other states, it really is to focus on both of those potential revenue streams, and really think about how we optimize them. Branded products will be a big part of it, but also the opportunity to capitalize on our expertise in cannabis extraction and provide quality white label products for others, we also see as a really big revenue stream for us.

James West: Okay, so in terms of owning additional states and territories, getting your products into other states, is it Halo’s sort of strategic direction to wait for Federal de-prohibition, or are you planning to sort of incrementally establish a presence in each of the states as it’s possible?

David Orr: I’d say it’s more the latter, for sure. I think the challenge for us, and probably like many others, is just to be as prudent and disciplined as you can. We want to go in and be able to have the same traction in the markets that we’ve had in the states that we’re in, so if three states opened up, you know, next week, I don’t think we’d be running over ourselves to try to get in all three; I think we’d look at each state, see which ones presented the best opportunities for us, see what the regulatory environment would be in each state, see which ones would allow us to optimize our kind of footprint, if you will, in those states. And we’d probably approach it in that way, as opposed to just chasing states as they open.

James West: Yeah, you bet. So you’re obviously got your eyes on Europe, as is evidenced by your Lesotho operations. Is the plan to offer, because Europe’s primarily medical at this point – is the plan to be able to ship product into the European market as a medical product?

David Orr: Yes, and I think we’re looking at both. You know, the thing that’s exciting and challenging at the same time is the speed at which the market is evolving. So I think, you know, Europe, much like many places in the US, started as medical; the thought with those markets would continue to evolve. I think for us right now, the footprint is to get in to Europe the way we can, which would be medical, but then be prepared to able to expand as that market potentially evolves. I think not much different here. You know, our product line currently is primarily THC, but we’re actively finding CBD lineups because there are going to be market opportunities for both, and I think, you know, that market might be more medical, but I think it’s going to be an evolution.   

James West: Yeah, you bet. Europe is slower moving than the rest of the world; what about Latin America?

David Orr: I’d say we see all the markets as potential opportunities, right? And I think Latin America is one that we’d be eager and anxious, and there’s a couple of places specifically we’ve talked about exploring. And I think that’s what we will continue to do. You know, Kiran is very forward thinking in how he’s thinking about approaching different markets as they open. So I’d say there’s probably not a market we’re not thinking about; again, I think the challenge for us is to try to be as pragmatic as possible and ensure that when we go   into the markets, we can have the same level of success that we’ve had thus far.

James West: Right. So do you think that there’s a likelihood that countries who ultimately gravitate towards legalization are going to try to protect the economic opportunity inherent in legalization for national companies, at the expense of international companies who would be importers into those countries?

David Orr: I don’t know. I think my answer would be largely speculative. I think I’d agree with you; yes, I think there will be some of that. I think as it becomes more political, as it gets more ingrained into the revenue streams and everybody’s thinking about how that would play out, I think you are going to have, just like in every other kind of industry, some lobbying, some kind of elbowing to try to see who could be first in line. We would say it would lend itself to some of the bigger, larger nationals, maybe shots at opportunities that others might not.

James West: Right. The landscape of pure extractors is pretty limited, globally, and really it’s, I mean, you can’t really argue with the idea that the pure extractors who have evolved and succeeded as pure extractors are, you know, very strong financially in terms of cost of capital, in terms of generating investor interest. And Halo, at this point, I would categorize as probably one of the least expensive among all of the pure extractors, and so, is it safe for me to conclude as an investor, without being too patronizing, that this is evidently an early-stage situation that might actually be undervalued?

David Orr: Absolutely. I think that’s more than fair, actually – and I don’t think it’s a stretch at all. I mean, if you look at our financials, if you look at where we are, you look at what we’re doing, I think any kind of look at that would say undervalued. But financials aside, I think what we continue to really continue to reinforce for us is the expertise and knowledge that we’ve built up in extraction. And I think as again, as the industry evolves, those that have proven expertise, understanding and knowledge, whether it be in cultivation, extraction, the retail space, I think all of those folks are going to be the ones that are the strongest and positioned for the most success, whether it be financially, stock-wise or other.

James West: Do you think there’s a risk that a price war evolves from commodification of the underlying feedstock, cannabis itself, as a result of the fact that it’s easy to grow and all countries are rushing towards growing it? How soon till we’re over-saturated, the price of cannabis collapses to the point where it makes no financial sense to fill these devices?

David Orr: Hopefully that’s a long way, but I do think there are real economic kind of factors that are in play, and I think candidly in the US, we’ve seen, whether it be in states like Colorado or Oregon, some of those dynamics that you just mentioned. And I think there’s going to be a number of things – I think the market is going to equalize, supply/demand equation. I think some of the regulation is going to come in. I think, candidly, the market is probably going to force some people out that don’t have the resources, expertise, depth of knowledge, to really survive. I think it will get to a point of survival, and then I think once you get past that, you will start to see, like in any other industry, the market itself start to really stabilize what it’ll be.

The commodity aspect is something that is always going to exist. It is, in many ways, a commoditizable product, so I think again, it’s going to be a shorter line of people that are able to really get in and stay in. But I do think there will be opportunities for those that are able to stay, to absolutely create models that make sense financially.

James West: You bet. All right, David, let’s leave it there for now. We’ll come back to you soon. Thanks for joining me today.

David Orr: Sounds great. Thanks a bunch. 

**IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY**

Notice for Forward-Looking Information

Certain statements in this press release are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such forward-looking information includes that HALO Labs Inc will be a big, successful company in the cannabis sector; that cannabis use and sales will grow and HALO’s sales along with it; HALO’s intended acquisition of various foreign companies and expansion into the US market; that extraction is and will continue to be a fast growing and profitable sector of the cannabis industry; that HALO will reach $48M in revenues in 2019; HALO’s plans to produce concentrates and sell them in various locations throughout the world; that HALO could be granted licenses to expand; and that it will be able to carry out its business plans.

Readers are cautioned to not place undue reliance on forward-looking information. Forward looking information is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from those contemplated in the forward-looking information, and even if such actual results or events are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on HALO. Such risks and uncertainties include, among other things: that a regulatory approval that may be required for the intended acquisitions and subsequent sales are not obtained or are obtained subject to conditions that are not anticipated; growing competition for intended acquisitions in the cannabis industry; potential future competition in the markets HALO operates for sales; competitors may quickly enter the industry; general economic conditions in the US, Canada and globally; the inability to secure financing necessary to carry out its business plans; competition for, among other things, capital and skilled personnel; the possibility that government policies or laws may not permit legal cannabis sales or growth or that favorable laws in place may change; HALO not adequately protecting its intellectual property; interruption or failure of information technology systems; the cannabis market may not grow as expected; HALO’s technology may not achieve the expected results and its accomplishments may be limited; even if it is granted patents, it may not have success at licensing its technologies or sell its products at the rate expected; planned acquisitions and partnerships may not materialize because of inability to agree on terms with prospective partners or targets; HALO’s business plan also carries risk, including its ability to comply with all applicable governmental regulations in a highly regulated business; incubator risk investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal and foreign laws; and other regulatory risks relating to HALO’s business, financings and strategic acquisitions, including securities laws, trade rules, and foreign country regulation that is not the same as Canadian or US regulations.

DISCLAIMERS

PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buy or sell securities. James West, Global Financial Network Ltd. and Midas Letter Media Corp. and their owners, managers, employees, and assigns (collectively “the Company”) has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by HALO $300,000 US dollars for a newsletter campaign and certain banner ads, and a budget of $450,000 is in place to place newsletters in social and other media. In addition, the Company owns 40,000 shares of HALO, and will benefit from its price appreciation. This compensation and our share ownership in HALO is a major conflict with our ability to be unbiased, more specifically:

This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in our newsletter and on our website may be based on end-of- day or intraday data. We have been compensated by HALO to conduct investor awareness advertising and marketing for HALO. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the profiled company. The profiled company or its affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our newsletters experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public and non-public sources but is not researched or verified in any way whatsoever to ensure the information is correct.

SHARE OWNERSHIP. The Company, which includes the owner and publisher of the Midas Letter may own shares and/or stock options of this featured company and therefore has an additional incentive to see the featured company’s stock perform well. The Company will not notify the market when it decides to buy or sell shares of this profiled company in the market. The Company may be buying and selling additional shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

NOT AN INVESTMENT ADVISOR. The Company and its affiliates are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities.

Free Newsletter,
Priceless Content.

Be the First to Hear from Midas Letter on Investment News, Videos, and More.